RecruitingNot Applicable

Clinical Trial of Concomitant Hip Arthroscopy During PAO

United States106 participantsStarted 2017-08-23

Plain-language summary

The study will assess the outcomes of patients treated with concomitant hip arthroscopy at the time of periacetabular osteotomy (PAO) for patients with hip dysplasia compared with patients treated with PAO alone.

Who can participate

Age range

15 Years – 55 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of hip dysplasia (DDH) electing periacetabular osteotomy (PAO) for treatment * Skeletally mature * Age 15 - 55 * Tonnis Grade 0 or 1 osteoarthritis (minimal or no arthritis) * Ability to receive a standard of care preoperative (magnetic resonance imaging) MRI arthrogram of the hip Exclusion Criteria: * Pregnant women * Previous surgery about the hip * Patients receiving PAO for acetabular retroversion in the absence of DDH * Previous hip arthroscopy to address intra-articular pathology

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Mean score of Hip Disability and Osteoarthritis Outcome (Hoos)

Timeframe: 1 year follow-up time point

Mean score of Western Ontario and McMaster Universities Arthritis Index (WOMAC)

Timeframe: 1 year follow-up time point

Mean score of University California Los Angeles (UCLA) activity assessment

Timeframe: 1 year follow-up time point

Mean score of the Marx Activity Scale (MARX)

Timeframe: 1 year follow-up time point

Trial details

NCT IDNCT03181048

SponsorMayo Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-06

Contact for this trial

Cody Wyles, MD

(507) 284-1175 wyles.cody@mayo.edu

View on ClinicalTrials.gov More Hip Dysplasia trials

Who can participate

Age range

15 Years – 55 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.